CORPHED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Corphed, and what generic alternatives are available?
Corphed is a drug marketed by Chartwell Rx and Endo Operations and is included in two NDAs.
The generic ingredient in CORPHED is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Corphed
A generic version of CORPHED was approved as ephedrine sulfate by SANDOZ on August 23rd, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORPHED?
- What are the global sales for CORPHED?
- What is Average Wholesale Price for CORPHED?
Summary for CORPHED
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| DailyMed Link: | CORPHED at DailyMed |
US Patents and Regulatory Information for CORPHED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | CORPHED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088602-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943-001 | Jan 27, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
